MDT

83.38

+1.89%↑

VEEV

215.75

+2.79%↑

A

102.85

+2.55%↑

WBA

10.98

+1.1%↑

CHE

579.48

+2.88%↑

MDT

83.38

+1.89%↑

VEEV

215.75

+2.79%↑

A

102.85

+2.55%↑

WBA

10.98

+1.1%↑

CHE

579.48

+2.88%↑

MDT

83.38

+1.89%↑

VEEV

215.75

+2.79%↑

A

102.85

+2.55%↑

WBA

10.98

+1.1%↑

CHE

579.48

+2.88%↑

MDT

83.38

+1.89%↑

VEEV

215.75

+2.79%↑

A

102.85

+2.55%↑

WBA

10.98

+1.1%↑

CHE

579.48

+2.88%↑

MDT

83.38

+1.89%↑

VEEV

215.75

+2.79%↑

A

102.85

+2.55%↑

WBA

10.98

+1.1%↑

CHE

579.48

+2.88%↑

Search

Hologic Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

58.13 2.05

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

56.94

Max

58.27

Pagrindiniai rodikliai

By Trading Economics

Pajamos

201M

Pardavimai

34M

1B

P/E

Sektoriaus vid.

18.019

59.668

Pelnas, tenkantis vienai akcijai

1.03

Pelno marža

19.671

Darbuotojai

7,063

EBITDA

51M

352M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+36.11% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-05-01

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-4B

13B

Ankstesnė atidarymo kaina

56.08

Ankstesnė uždarymo kaina

58.13

Naujienos nuotaikos

By Acuity

20%

80%

49 / 382 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bearish Evidence

Hologic Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-04-22 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Union Says Nippon Steel Can't Be Trusted With Buying U.S. Steel

2025-04-22 20:55; UTC

Uždarbis

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

2025-04-22 23:49; UTC

Rinkos pokalbiai

Nikkei May Rise After Wall Street Rally -- Market Talk

2025-04-22 23:49; UTC

Rinkos pokalbiai

Gold Falls on Signs of Easing U.S.-China Tensions, Possible Profit-Taking -- Market Talk

2025-04-22 23:47; UTC

Svarbiausios naujienos

Trump Says He Has 'No Intention' of Firing Fed Chair Powell -- 4th Update

2025-04-22 23:08; UTC

Įsigijimai, susijungimai, perėmimai

Woodside: No Change to Annual Guidance

2025-04-22 23:07; UTC

Įsigijimai, susijungimai, perėmimai

Woodside: Assessing Impacts of Recent Tariff Announcements on Louisiana LNG

2025-04-22 23:07; UTC

Įsigijimai, susijungimai, perėmimai

Woodside: Advancing Talks Targeting Further Equity Selldown in Louisiana LNG

2025-04-22 23:06; UTC

Įsigijimai, susijungimai, perėmimai

Woodside: Trion Project 26% Complete, on Track for First Oil in 2028

2025-04-22 23:05; UTC

Įsigijimai, susijungimai, perėmimai

Woodside: Scarborough Energy Project on Track for First LNG Cargo in 2H 2026

2025-04-22 23:05; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy: Scarborough Energy Project 82% Complete

2025-04-22 23:05; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy: Beaumont New Ammonia Project on Track to Start in 2H

2025-04-22 23:05; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy: Beaumont New Ammonia Project 90% Complete

2025-04-22 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy: Share of Sangomar Production Maintained at 78 Million Bbl/Day in 1Q

2025-04-22 23:04; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Macquarie Set for A$500 Million Gain on Sale From Nomura Deal -- Market Talk

2025-04-22 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy Sold 25.4% of Produced LNG at Prices Linked to Gas Hub Indices in 1Q

2025-04-22 23:03; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy Cites Lower Output, Reduced Oil-Linked Prices for Revenue Fall

2025-04-22 23:03; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy 1Q Revenue Down 5% on Prior Quarter

2025-04-22 23:03; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy 1Q Revenue US$3.315 Billion

2025-04-22 23:02; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Cites Weather Impacts at North West Shelf, Pluto Unplanned Outages in 1Q

2025-04-22 23:02; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy 1Q Oil, Natural Gas Output Down 4% on Prior Quarter

2025-04-22 23:01; UTC

Įsigijimai, susijungimai, perėmimai

Woodside Energy 1Q Oil, Natural Gas Output 49.1 Million BOE

2025-04-22 22:31; UTC

Uždarbis

Tesla Profit Sinks, Hurt by Backlash Over Elon Musk's Political Role -- Update

2025-04-22 22:26; UTC

Svarbiausios naujienos

Trump Is Laying the Groundwork to Blame Powell for Any Downturn -- Update

2025-04-22 22:16; UTC

Svarbiausios naujienos

Trump Says He Has 'No Intention' of Firing Fed Chair Powell -- 3rd Update

2025-04-22 22:16; UTC

Rinkos pokalbiai

Turkey Remains on Course for Steadily Lower Inflation, Finance Minister Says -- Market Talk

2025-04-22 22:04; UTC

Svarbiausios naujienos

China Tariffs 'Won't Be Anywhere Near' 145%: Trump -- Barrons.com

2025-04-22 21:42; UTC

Uždarbis

Tesla Profit Sinks, Hurt by Backlash Over Elon Musk's Political Role -- WSJ

2025-04-22 21:21; UTC

Svarbiausios naujienos
Uždarbis

Tesla Profit Sinks, Hurt by Political Backlash -- 3rd Update

2025-04-22 21:19; UTC

Svarbiausios naujienos

Investors Hope for No Surprises as Boeing Reports Earnings -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Hologic Inc Prognozė

Kainos tikslas

By TipRanks

36.11% į viršų

12 mėnesių prognozė

Vidutinis 77.5 USD  36.11%

Aukščiausias 90 USD

Žemiausias 70 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Hologic Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

10 ratings

3

Pirkti

7

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

56.505 / 57.85Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Weak Bearish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Strong Bearish Evidence

Rinkos nuotaikos

By Acuity

49 / 382 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.